SG11201908574TA - Herbal composition - Google Patents

Herbal composition

Info

Publication number
SG11201908574TA
SG11201908574TA SG11201908574TA SG11201908574TA SG 11201908574T A SG11201908574T A SG 11201908574TA SG 11201908574T A SG11201908574T A SG 11201908574TA SG 11201908574T A SG11201908574T A SG 11201908574TA
Authority
SG
Singapore
Prior art keywords
international
herbal composition
herbal
road
management
Prior art date
Application number
Inventor
Patanjali Subramoni
Sundaram Chandrasekharan
Jayashree Madhavan
Anilkumar K
Sarala Samuel
Bishwajit Nag
Ramesh Vangal
Nitish Nag
Jayarajan Kodikannath
Original Assignee
Kerala Ayurveda Ltd India
Katra Phytochem India Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerala Ayurveda Ltd India, Katra Phytochem India Private Ltd filed Critical Kerala Ayurveda Ltd India
Publication of SG11201908574TA publication Critical patent/SG11201908574TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

FirstHerb Blend faircuma longs, Emblica officinalla Vemonla unthelmintica, TInospora cord folk, Trigonella foenum-graecum, Ixora coccinea, Sysygium aiming Ilydro alcohol Exit - 'Lion Second Herb Blend pircrima long, Emblica o[ricinalisl Hydro al 'oho] Extract. First Herb Extract Second Herb extract Mixing of both extracts Concentration Herbal Composition Drying Blending Packing FIG.1 W O 20 18/ 1677 35 Al (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 20 September 2018 (20.09.2018) WIPO I PCT o °nolo Oil 100 momilomomo oimIE (10) International Publication Number WO 2018/167735 Al (51) International Patent Classification: A61K 36/00 (2006.01) A61K 36/9066 (2006.01) A61K 36/59 (2006.01) A61P 3/10 (2006.01) (21) International Application Number: PCT/IB2018/051790 (22) International Filing Date: 18 March 2018 (18.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/473,126 17 March 2017 (17.03.2017) US (71) Applicants: KERALA AYURVEDA LIMITED (INDIA) [IN/IN]; Athani Post, Aluva, Ernakulam District, Kerala 683585 (IN). KATRA PHYTOCHEM (INDIA) PRIVATE LIMITED [IN/IN]; 1134, First Floor, 100 Feet Road, HAL 2nd Stage, Indiranagar, Bangalore 560008 (IN). (72) Inventors: SUBRAMONI, Patanjali; 259, 2nd Main, 4th Cross, Sai Enclave, Kothnur, Bangalore, Karnataka 560076 (IN). CHANDRASEKHARAN, Sundaram; E 117, Habi- tat Splendour, Gopalan Enterprises, Next to CMR Institute, Kundanahalli, Bangalore, Karnataka 560037 (IN). MAD- HAVAN, Jayashree; 1080-18/1, 3rd 'IT main Road, 'E' Block, II stage, Rajajinagar, Bangalore, Karnataka 560010 (IN). K, Anilkumar; Sreerangam, 8/502, Krishnaswamy Temple Road, Aluva, Kerala 683101 (IN). SAMUEL, Sar- ala; Kochakkan House, Carmelgiri Semminary Road, U. C. College P. 0., Aluva 2, Ernakulam District, Kerala 682102 (IN). NAG, Bishwajit; 4579 Martin Street, Union City, California 94587 (US). VANGAL, Ramesh; Blk 04-09, Nassim Jade, No.3 Nassim Road, Singapore 258371 (SG). NAG, Nitish; 4579 Martin Street, Union City, California 94587 (US). KODIKANNATH, Jayarajan; 34471 Hel- ston Pl, Fremont, California 94555 (US). (74) Agent: VASHISHTHA, Bhavana; A-1/701, Olive Coun- ty, Sector-5, Vasundhara, Ghaziabad, Uttar Pradesh 201012 (IN). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (54) Title: HERBAL COMPOSITION (57) : The present invention generally relates to an herbal composition effective in management of disorders related to metabolic syndrome. More particularly, the invention relates to an herbal com- position effective in the management of disorders related to metabolic syndrome such as Type 2 diabetes mellitus, obesity and lipid profile management and a process for the preparation of such an herbal com- position. The invention further relates to the use of the herbal com- position in preparation of food supplements, pharmaceuticals and nu- traceuticals for the management of disorders related to metabolic syn- drome. The herbal composition effective in management of metabol- ic syndrome related disorders comprises of herbs selected from Cur- cuma longa, Emblica offcinalis, Vernonia anthelmintica, Tinospora- cordifolia, Trigonella foenum-graecum, Ixora coccinea Syzygium and cumini. Also provided is the use of herbal composition for the treat- ment of disorders related to metabolic syndrome. Also provided is a method of treating disorders related to metabolic syndrome compris- ing administering to a subject in need thereof a therapeutically effec- tive amount of the herbal composition of the present invention. [Continued on next page] WO 2018/167735 Al MIDEDIMOMOIDEIREEMOMMINEEHOMEOMEHOIMI SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) of inventorship (Rule 4.17(iv)) Published: with international search report (Art. 21(3)) in black and white; the international application as filed contained color or greyscale and is available for download from PATENTSCOPE
SG11201908574T 2017-03-17 2018-03-18 Herbal composition SG11201908574TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762473126P 2017-03-17 2017-03-17
PCT/IB2018/051790 WO2018167735A1 (en) 2017-03-17 2018-03-18 Herbal composition

Publications (1)

Publication Number Publication Date
SG11201908574TA true SG11201908574TA (en) 2019-10-30

Family

ID=63521868

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908574T SG11201908574TA (en) 2017-03-17 2018-03-18 Herbal composition

Country Status (6)

Country Link
US (1) US11491202B2 (en)
EP (1) EP3595691A4 (en)
JP (1) JP7254727B2 (en)
KR (1) KR20190132420A (en)
SG (1) SG11201908574TA (en)
WO (1) WO2018167735A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075567B (en) * 2019-05-28 2021-09-28 河北万邦复临药业有限公司 Centrifugal device and method combining high-pressure spraying with countercurrent sedimentation
EP4045071A4 (en) * 2019-10-15 2023-11-29 Sami-Sabinsa Group Limited Curcuminoid composition for therapeutic management of metabolic syndrome
CN115414403B (en) * 2022-10-09 2023-06-20 江苏海洋大学 Application of phyllanthus emblica extract in preparation of marine vibrio resisting medicine
CN115944694B (en) * 2022-11-01 2023-09-29 江苏省中医院 Compound combination medicine, traditional Chinese medicine preparation and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020218A2 (en) * 2001-08-30 2003-03-13 Taipei-Veterans General Hospital Salvianolic acid b
EP1974737A1 (en) * 2007-03-23 2008-10-01 Phyto Health Pharma B.V. Composition for the treatment of diabetes mellitus and metabolic syndrome
WO2009098702A2 (en) 2008-02-06 2009-08-13 Sadashiv Damle Ramchandra A hypoglycemic herbal extract composition for reducing blood sugar levels in mammals
US8410079B2 (en) * 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
SG189529A1 (en) * 2010-10-25 2013-06-28 Manu Chaudhary A detoxifier herbal formulation

Also Published As

Publication number Publication date
US20200085904A1 (en) 2020-03-19
EP3595691A1 (en) 2020-01-22
WO2018167735A1 (en) 2018-09-20
KR20190132420A (en) 2019-11-27
JP7254727B2 (en) 2023-04-10
EP3595691A4 (en) 2020-11-25
JP2020514416A (en) 2020-05-21
US11491202B2 (en) 2022-11-08

Similar Documents

Publication Publication Date Title
SG11201908574TA (en) Herbal composition
SG11201909155VA (en) Ask1 inhibitor compounds and uses thereof
SG11201810023QA (en) Anti-tim-3 antibodies and methods of use thereof
SG11201900975XA (en) Formulation for inhibiting formation of 5-ht 2b agonists and methods of using same
SG11201811432WA (en) Rna for cancer therapy
SG11201811230RA (en) Compositions and methods for reducing ocular neovascularization
Quintans-Júnior et al. Citral reduces nociceptive and inflammatory response in rodents
SG11201907753TA (en) Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereof
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201900845YA (en) Uses of il-13 antagonists for treating atopic dermatitis
SG11201808911SA (en) Trispecific and/or trivalent binding proteins
SG11201910027YA (en) Bispecific antibody against ox40 and ctla-4
SG11201808990QA (en) Compositions for topical application of compounds
SG11201810210UA (en) Engineered botulinum neurotoxins
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201807306XA (en) Uniqueness level for anonymized datasets
SG11201806127XA (en) Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate
SG11201804961UA (en) Formulations with reduced degradation of polysorbate
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201909334TA (en) Proteins for the treatment of epithelial barrier function disorders
SG11201909837YA (en) Methods for treating lung disorders
SG11201901597UA (en) Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof
SG11201909419XA (en) Hydrogel for cell culture and biomedical applications
SG11201901228QA (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide